Enlivex ENLV
NASDAQ ENLV
$1.04 -0.07 (-6.31%)
At close: Sep 9, 2026 · 4:00 PM EDT

Enlivex (ENLV) Non Operating Interest Expenses (2013 - 2020)

Enlivex (ENLV) posted Non Operating Interest Expenses of $2.1 million for Q4 2020, up 1051.57% on a QoQ basis from -$223000.0 in Q3 2020, and up 27.29% year-over-year from $1.7 million in Q1 2020.

Analysis

Enlivex (ENLV) Non Operating Interest Expenses (2013 - 2020) Analysis & Trends

Enlivex has reported Non Operating Interest Expenses for 7 years, with the latest figure at $2.1 million in Q4 2020.

  • On a quarterly basis, Non Operating Interest Expenses rose 27.29% year-over-year to $2.1 million in Q4 2020; TTM through Dec 2020 was $2.8 million, a 139.01% increase from a year earlier, with the FY2025 full-year figure at $29000.0, down 91.76% from the prior year.
  • Non Operating Interest Expenses was $2.1 million for Q4 2020 at Enlivex, up from -$223000.0 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $2.1 million in Q4 2020, with the low at -$358000.0 in Q1 2019.
  • Average Non Operating Interest Expenses over 4 years is $351615.4, with a median of $5000.0 recorded in 2018.
  • The largest YoY upside for Non Operating Interest Expenses was 33240.0% in 2019 against a maximum downside of 34100.0% in 2019.
  • Over 4 years, Non Operating Interest Expenses stood at $592000.0 in 2017, then sank by 99.16% to $5000.0 in 2018, then surged by 33240.0% to $1.7 million in 2019, then advanced by 27.29% to $2.1 million in 2020.
  • The last three Non Operating Interest Expenses figures came in at $2.1 million (Q4 2020), -$223000.0 (Q3 2020), and $897000.0 (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Enlivex 3.17 Mn -2.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2.12 Mn
Sep 30, 2020 -223,000.00
Jun 30, 2020 897,000.00
Mar 31, 2020 -2,000.00
Dec 31, 2019 1.67 Mn
Sep 30, 2019 -342,000.00
Jun 30, 2019 202,000.00
Mar 31, 2019 -358,000.00
Dec 31, 2018 5,000.00
Sep 30, 2018 -1,000.00
Jun 30, 2018 -3,000.00
Mar 31, 2018 15,000.00
Dec 31, 2017 592,000.00
Jun 30, 2015 -55,000.00
Mar 31, 2015 -21,000.00
Dec 31, 2014 50,000.00
Sep 30, 2014 -19,000.00
Jun 30, 2014 2,000.00
Mar 31, 2014 4,000.00
Dec 31, 2013 -7,000.00